Online citations, reference lists, and bibliographies.
← Back to Search

Melanoma-associated Retinopathy: Screening For Melanoma-associated Retinopathy In Patients With Cutaneous Malignant Melanoma

A. H. Haus, A. Palmowski, C. Pföhler, U. Reinhold, C. Gantenbein, C. Thirkill, Rainer Allgayer, W. Tilgen, K. Ruprecht
Published 2002 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Purpose: Melanoma-associated retinopathy (MAR) is a paraneoplastic retinopathy that develops in some patients with cutaneous malignant melanoma (CMM).The syndrome is identified by, and possibly caused by, antibodies reactive with retinal depolarizing bipolar cells. CMM patients lacking indications of vision problems are not usually routinely screened for melanoma-induced retinal hypersensitivity, but may have undergone similar sensitization without losing tolerance or may be in the early stages of MAR. The purpose of this study was to look into the possibility that subclinical and immunologic indications of MAR appear in CMM patients without recognized retinopathies. Methods: Twenty-nine CMM patients (stages II-IV), being treated at the Department of Dermatology (The Saarland University Hospital), were screened to detect abnormalities suggestive of MAR. Our assessment included exploration of ophthalmologic history, ophthalmologic examination, electrophysiology, nyctometry, perimetry, testing of color vision, and serum examination for antiretinal autoantibodies. Parameters for diagnosing MAR were (1) reduced scotopic b-wave amplitude, (2) reduced contrast sensitivity in nyctometry, (3) abnormalities in perimetry, and (4) the identification of antiretinal antibodies, especially against the retinal bipolar cell layer. Results: Two patients had to be excluded due to either bad compliance (n = 1) or a clouding of the media (n = 1). Six of the remaining 27 patients were found to exhibit indications of MAR, showing abnormal results in all of the clinical examinations 1-3. Three of these six patients produced antibodies reactive with ocular tissue, including retinal bipolar cells. These three patients were accordingly classified as affected by MAR. These findings indicate a prevalence of MAR in approximately 10% of the study group. Eighteen of the remaining patients produced abnormal results in at least one of the evaluations for MAR. Patients with MAR-suspicious signs frequently had abnormalities in the Farnsworth Panel D15 tests, mostly in the tritan axis or involving all three color axes at the same time. Conclusions: MAR is widely considered to be a rare, immune-mediated paraneoplastic syndrome. Our screening for indications of MAR in CMM patients identified a much higher prevalence than expected. Impaired color vision in a CMM patient indicates the need for MAR screening.
This paper references
10.3109/09273949509085040
An unusual case of melanoma-associated retinopathy.
B. B. Okel (1995)
Multifocal electroretinogram in myopia.
H. Kawabata (1997)
10.1016/S0002-9394(98)00431-0
Cutaneous melanoma-associated paraneoplastic retinopathy: histopathologic observations.
J. Gittinger (1999)
'On' response defect in paraneoplastic night blindness with cutaneous malignant melanoma.
K. Alexander (1992)
10.1001/ARCHOPHT.1991.01080020020008
Retinitis pigmentosa misdiagnosed as complicated migraine.
C. J. Mackay (1991)
10.1177/112067219600600221
Selective damage to either the "M" or "P" cell pathway in human retinal disease: implications for visual processing.
Wolf Je (1996)
Melanomaassociated retinopathy
A D Singh (1995)
10.1016/S0161-6420(94)31183-3
Paraneoplastic Retinopathy Associated with Andretinal Bipolar Cell Antibodies in Cutaneous Malignant Melanoma
J. Weinstein (1994)
Unilateral manifestation of melanoma-associated retinopathy.
M. Janáky (2002)
10.1006/EXER.1996.0124
Sinclair swine with spontaneously regressing cutaneous melanomas do not have autoantibodies against retinal bipolar cells.
K. Alexander (1996)
Melanoma-associated paraneoplastic retinopathy: a case report and update
M B Rougier (1995)
Bilateral multifocal chorioretinopathy in a woman with cutaneous malignant melanoma.
A. Palmowski (2002)
Human melanoma-associated retinopathy (MAR) antibodies alter the retinal ON-response of the monkey ERG in vivo.
B. Lei (2000)
10.1016/0042-6989(95)00316-9
Selective Magnocellular Damage in Melanoma-associated Retinopathy: Comparison with Congenital Stationary Nightblindness
J. Wolf (1996)
10.1097/00041327-200109000-00004
Clinical and Immunologic Characteristics of Melanoma-Associated Retinopathy Syndrome: Eleven New Cases and a Review of 51 Previously Published Cases
J. Keltner (2001)
10.1177/112067219600600221
Selective damage to either the "M" or "P" cell pathway in human retinal disease: implications for visual processing.
J. Wolf (1996)
10.1001/ARCHOPHT.1995.01100070024015
Cutaneous melanoma-associated retinopathy with retinal periphlebitis.
J. Remulla (1995)
Identification of antibodies in serum of patients with melanomaassociated retinopathy (Abstract)
C Pföhler (2001)
Functional abnormalities in vincristine-induced night blindness.
H. Ripps (1984)
10.1001/ARCHOPHT.117.12.1641
Cancer-associated retinopathy.
S. Goldstein (1999)
10.1016/S0161-6420(94)31092-X
Cutaneous melanoma-associated retinopathy.
R. Y. Kim (1994)
[Nyctometry findings in different age groups].
W. Lehnert (1967)
10.1159/000027503
Melanoma-Associated Retinopathy versus Abnormal Retinal Function due to Interferon-α/Isotretinoin Therapy in Cutaneous Malignant Melanoma
B. Feigl (2000)
Paraneoplastic retinopathy in malignant melanoma (Letter)
JA Rush (1993)
10.1001/ARCHOPHT.1991.01080020020009
Retinitis Pigmentosa Misdiagnosed as Complicated Migraine-Reply
L. Dubois (1991)
Cutaneous melanomaassociated retinopathy with retinal periphlebitis (Letter)
JF Remulla (1995)
[Melanoma-associated retinopathy. Apropos of a case and review of the literature].
C. Bret-Dibat (1996)
10.1076/0927-3948(200003)811-SFT025
Retinal pigment epithelial hypersensitivity, an association with vision loss: RPE hypersensitivity complicating paraneoplastic retinopathies
C. Thirkill (2000)
Melanoma-associated retinopathy accompanied by night blindness -a case report
M Klopfer (1997)
10.1016/S0042-6989(96)00318-5
Hepatic Retinopathia. Changes in Retinal Function
A. Eckstein (1997)
Autoantibodies against retinal bipolar cells in cutaneous melanoma-associated retinopathy.
A. Milam (1993)
Electrophysiological features of melanoma associated retinopathy (MAR) (ARVO Abstract)
GE Holder (2000)
[Paraneoplastic retinopathy associated with cutaneous melanoma. An update apropos of a case].
M. Rougier (1995)
10.1016/S0002-9394(14)76622-X
Paraneoplastic night blindness with malignant melanoma.
E. Berson (1988)
Acute Vogt-Koyanagi-Harada like syndrome occurring in a patient with metastatic cutaneous melanoma
Jdm Gass (1984)
Antiretinal Müller cell antibodies in patients with melanoma associated and autoimmune retinopathy
M F Flynn (2000)
A retinal bipolar cell protein is recognized by autoantibodies from patients with melanoma-associated retinopathy
H Ohguro (1999)
10.1038/eye.1997.227
Paraneoplastic retinopathy associated with metastatic cutaneous melanoma of unknown primary site
H. Kıratlı (1997)
10.1016/0042-6989(92)90235-B
The field topography of ERG components in man—I. The photopic luminance response
E. Sutter (1992)
10.1046/j.1365-2133.1997.18701958.x
Melanoma‐associated paraneoplastic retinopathy: case report and review of the literature
K. Boeck (1997)
10.1001/ARCHOPHT.1993.01090030068041
Interferon-associated retinopathy.
D. Guyer (1993)
10.1007/BF00140542
The electroretinographic characteristics of congenital tritan defects
K. Shinzato (2004)
10.1016/S0166-2236(99)01458-7
Rod pathways: the importance of seeing nothing
L. Sharpe (1999)
10.1111/j.1755-3768.1993.tb04623.x
Full‐field electroretinogram in a patient with cutaneous melanoma‐associated retinopathy
S. Andréasson (1993)
10.1007/s003470050159
Melanom-assoziierte Retinopathie (MAR) mit Nachtblindheit Fallbericht
M. Klopfer (1997)
10.1136/bjo.79.8.746
Severe course of cutaneous melanoma associated paraneoplastic retinopathy.
U. Kellner (1995)
10.1097/00041327-199906000-00001
The 22-kDa antigen in optic nerve and retinal diseases.
J. Keltner (1999)
10.1016/S0161-6420(99)90493-1
Clinical and immunocytochemical findings in a case of melanoma-associated retinopathy.
M. J. Potter (1999)
An unusual case of melanomaassociated retinopathy
BB Okel (1995)
Perimetrie : mit besonderer Berücksichtigung der automatischen Perimetrie
B. Gloor (1993)
Anforderungen an die Übung der Nachtfahrtauglichkeit und eine neue technische Möglichkeit für ihre Durchführung
G Guilino (1979)
10.1016/0166-2236(90)90187-F
Rod pathways in mammalian retinae
N. Daw (1990)
Inner retinal layer loss in complicated migraine. Case report.
L. Dubois (1988)
10.1136/bjo.85.3.291
Distant cancer effects on standardised testing of peripheral vision
W. Dawson (2001)
10.1136/bjo.80.9.850
Unilateral choroidal melanoma with bilateral retinal vasculitis.
D. Steel (1996)
10.1097/00041327-199512000-00020
Paraneoplastic retinopathy associated with antiretinal bipolar cell antibodies in cutaneous malignant melanoma.
J. Weinstein (1994)
10.1016/S0002-9394(14)73594-9
Paraneoplastic retinopathy in malignant melanoma.
J. A. Rush (1993)
The visual field in normal subjects.
K. Egge (1984)
Blue cone function in a family with an inherited tritan defect, tested with electroretinography and psychophysics.
P. Padmos (1978)
10.1016/S0002-9394(01)01086-8
Melanoma-associated retinopathy and recurrent exudative retinal detachments in a patient with choroidal melanoma.
D. Zacks (2001)
10.1001/ARCHOPHT.1988.01060140187016
Inner Retinal Layer Loss in Complicated Migraine
L. Dubois (1988)
10.1016/S0039-6257(00)00133-8
Node way out.
M. Vaphiades (2000)
10.1016/S0002-9394(02)01431-9
Autoantibodies to transducin in a patient with melanoma-associated retinopathy.
M. J. Potter (2002)
10.1046/j.1442-9071.2001.00425.x
Melanoma‐associated retinopathy: does autoimmunity prolong survival?
C. Chan (2001)



This paper is referenced by
10.1007/3-540-28988-7_15
Melanomassoziierte Retinopathie als Prognosefaktor
C. Pföhler (2006)
10.1016/J.ORET.2016.11.004
Use for Vemurafenib in Metastatic Cutaneous Melanoma to the Choroid and Presumed Melanoma-Associated Retinopathy.
G. Singh (2017)
10.1371/journal.pone.0069506
Serum TRPM1 Autoantibodies from Melanoma Associated Retinopathy Patients Enter Retinal ON-Bipolar Cells and Attenuate the Electroretinogram in Mice
W. Xiong (2013)
10.1097/00006982-200512000-00018
Bilateral macular hemorrhage associated with autoimmune hemolytic anemia.
A. Oner (2005)
10.1007/s00347-005-1265-8
Unilaterale nächtliche Blendempfindung und Photopsien
M. Todorova (2005)
10.1097/01.CMR.0000222599.35062.84
Frequency of colour vision deficiencies in melanoma patients: results of a prospective comparative screening study with the Farnsworth panel D 15 test including 300 melanoma patients and 100 healthy controls
C. Pföhler (2006)
10.1097/00006982-200512000-00020
Cancer-associated retinopathy in a patient with hepatocellular carcinoma: case report and literature review.
P. Chang (2005)
10.1002/ijc.22384
Mitofilin and titin as target antigens in melanoma‐associated retinopathy
C. Pföhler (2007)
"Retrospektive Untersuchung zum progressfreien und Gesamtüberleben von Melanompatienten in Abhängigkeit vom Vorhandensein anti-retinaler Serumantikörper"
Klinik für Dermatologie (2008)
10.1111/j.1365-2133.2005.06480.x
Incidence of antiretinal antibodies in melanoma: screening of 77 serum samples from 51 patients with American Joint Committee on Cancer stage I–IV
G. Ladewig (2005)
10.1111/ced.14095
Melanoma‐associated retinopathy
S. El-Sheikh (2019)
Semantic Scholar Logo Some data provided by SemanticScholar